<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43191">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02544074</url>
  </required_header>
  <id_info>
    <org_study_id>2014H0039</org_study_id>
    <nct_id>NCT02544074</nct_id>
  </id_info>
  <brief_title>Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)</brief_title>
  <acronym>eSAGE</acronym>
  <official_title>Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Douglas Scharre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brain Test, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Self-Administered Gerocognitive Examination (SAGE) is a valid and reliable cognitive
      assessment tool used to identify both Mild Cognitive Impairment (MCI) and early dementia.
      SAGE's self-administered feature, pen and paper format, and four equivalent interchangeable
      forms allows it to be given in almost any setting, does not require any staff time to
      administer and makes it practical to rapidly screen large numbers of individuals in the
      community or in their home.This trial is being conducted to study the validity of SAGE in a
      digital format (eSAGE) for cognitive screening.

      The investigators will analyze the data to learn the correlations between eSAGE and gold
      standard neuropsychological testing designed to differentiate normal cognition from MCI and
      early dementia. The investigators will also find out whether the paper (SAGE) and electronic
      (eSAGE) versions of SAGE could be used interchangeably or not.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be recruited based on their eSAGE scores and evaluated with
      neuropsychological testing and medical history to determine their status as normal, mild
      cognitive impairment, or dementia.

      The investigators will analyze the data to learn the correlations between eSAGE and gold
      standard neuropsychological testing designed to differentiate normal cognition from MCI and
      early dementia. The investigators will also find out whether the paper (SAGE) and electronic
      (eSAGE) versions of SAGE could be used interchangeably or not.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>eSAGE score compared to the sum of the neuropsychological measures.</measure>
    <time_frame>3 Hours</time_frame>
    <description>Analysis will consist of comparing the subject's scores on the SAGE in digital format to their neuropsychological test scores using correlational methods. This will be a composite score of the neuropsychological testing scores. The neuropsychological measures include:
Mini-Mental State Examination (MMSE)
Montreal Cognitive Assessment (MoCA)
Boston Naming Test
Wisconsin Card Sort Task (WCST)
Hopkins Verbal Learning Test (HVLT)
FAS verbal fluency task
Wechsler Adult Intelligence Scale III (WAIS III) Letter-number and block design subtests</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>eSAGE score compared to paper SAGE score</measure>
    <time_frame>3 hours</time_frame>
    <description>The investigators will compare the paper SAGE with the digital format of SAGE to determine if these two formats are equivalent to each other.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eSAGE score compared to the Mini-Mental State Examination (MMSE) exam score</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eSAGE score compared to the Montreal Cognitive Assessment (MoCA) score</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eSAGE score compared to the Boston Naming Test score</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eSAGE score compared to the Wisconsin Card Sort Task (WCST) score</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eSAGE score compared to the Hopkins Verbal Learning Test (HVLT) score</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eSAGE score compare to the FAS verbal fluency task score</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eSAGE score compared to the Wechsler Adult Intelligence Scale III (WAIS III) Letter-number score</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eSAGE score compared to the Wechsler Adult Intelligence Scale III (WAIS III) block design score</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <number_of_groups>21</number_of_groups>
  <enrollment type="Actual">69</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Dementia</condition>
  <arm_group>
    <arm_group_label>eSAGE score of 10</arm_group_label>
    <description>Participants who score a 10 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 11</arm_group_label>
    <description>Participants who score an 11 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 12</arm_group_label>
    <description>Participants who score a 12 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 13</arm_group_label>
    <description>Participants who score a 13 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 14</arm_group_label>
    <description>Participants who score a 14 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 15</arm_group_label>
    <description>Participants who score a 15 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 16</arm_group_label>
    <description>Participants who score a 16 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 17</arm_group_label>
    <description>Participants who score a 17 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 18</arm_group_label>
    <description>Participants who score a 18 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 19</arm_group_label>
    <description>Participants who score a 19 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 20</arm_group_label>
    <description>Participants who score a 20 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 21</arm_group_label>
    <description>Participants who score a 21 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 22</arm_group_label>
    <description>Participants who score a 22 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 9</arm_group_label>
    <description>Participants who score a 9 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 8</arm_group_label>
    <description>Participants who score an 8 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 6</arm_group_label>
    <description>Participants who score a 6 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 7</arm_group_label>
    <description>Participants who score a 7 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 5</arm_group_label>
    <description>Participants who score a 5 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 4</arm_group_label>
    <description>Participants who score a 4 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 3</arm_group_label>
    <description>Participants who score a 10 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eSAGE score of 2</arm_group_label>
    <description>Participants who score a 2 on the eSAGE. Interventions include neuropsychological testing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>neuropsychological testing</intervention_name>
    <description>standard neuropsychological testing including brief standardized assessments</description>
    <arm_group_label>eSAGE score of 10</arm_group_label>
    <arm_group_label>eSAGE score of 11</arm_group_label>
    <arm_group_label>eSAGE score of 12</arm_group_label>
    <arm_group_label>eSAGE score of 13</arm_group_label>
    <arm_group_label>eSAGE score of 14</arm_group_label>
    <arm_group_label>eSAGE score of 15</arm_group_label>
    <arm_group_label>eSAGE score of 16</arm_group_label>
    <arm_group_label>eSAGE score of 17</arm_group_label>
    <arm_group_label>eSAGE score of 18</arm_group_label>
    <arm_group_label>eSAGE score of 19</arm_group_label>
    <arm_group_label>eSAGE score of 20</arm_group_label>
    <arm_group_label>eSAGE score of 21</arm_group_label>
    <arm_group_label>eSAGE score of 22</arm_group_label>
    <arm_group_label>eSAGE score of 9</arm_group_label>
    <arm_group_label>eSAGE score of 8</arm_group_label>
    <arm_group_label>eSAGE score of 6</arm_group_label>
    <arm_group_label>eSAGE score of 7</arm_group_label>
    <arm_group_label>eSAGE score of 5</arm_group_label>
    <arm_group_label>eSAGE score of 4</arm_group_label>
    <arm_group_label>eSAGE score of 3</arm_group_label>
    <arm_group_label>eSAGE score of 2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be recruited from a wide variety of community events including senior
        centers, health fairs, educational talks to lay public, independent and assisted living
        facilities, and free memory screens as well as from ambulatory Geriatric or Memory
        Disorders Clinics. The SAGE cognitive screening tool will be given to all subjects willing
        to take the test.Participants who complete the SAGE test and meet inclusion and exclusion
        criteria will be divided into groups based on their initial SAGE scores. Each group will
        be composed of subjects with the same score. Individuals will be randomly selected from
        each group and asked to further participate in a one-time clinical evaluation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults over 49 years old of either gender

          -  Vision and hearing sufficient for compliance with tests

        Exclusion Criteria:

          -  Diagnosis by a physician of moderate or severe dementia

          -  Intellectual disability
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas Scharre, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 23, 2016</lastchanged_date>
  <firstreceived_date>March 18, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The Ohio State University</investigator_affiliation>
    <investigator_full_name>Douglas Scharre</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cognition Disorders</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Mild Cognitive Impairment</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
